T. Rowe Price Investment Management, Inc. - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 226 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$210,204
+20.0%
8,324,884
+0.2%
0.15%
+25.2%
Q2 2023$175,222
+22.1%
8,304,314
-1.3%
0.12%
+15.5%
Q1 2023$143,484
-14.2%
8,415,430
+0.5%
0.10%
-19.5%
Q4 2022$167,327
-99.9%
8,374,675
+3.8%
0.13%
-7.9%
Q3 2022$173,759,0008,066,7620.14%
Other shareholders
INSMED INC shareholders Q4 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,889,491$100,415,8228.32%
Deep Track Capital, LP 6,500,000$110,825,0004.55%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,932,138$49,992,9532.11%
Endurant Capital Management LP 230,006$3,921,6022.01%
Ikarian Capital, LLC 485,000$8,269,2501.88%
MPM BioImpact LLC 399,192$6,806,2241.77%
SECTORAL ASSET MANAGEMENT INC 516,092$8,799,3691.69%
Novo Holdings A/S 1,339,304$22,835,1331.51%
First Light Asset Management, LLC 750,883$12,802,5551.15%
SILVERARC CAPITAL MANAGEMENT, LLC 143,794$2,451,6881.01%
View complete list of INSMED INC shareholders